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(From The Rockefeller University, New York 10021) 
On the basis of the responses (1-3) of intact liver as well as of cultured hepato- 
cytes to exogenously administered heme (Fe-protoporphyrin-IX,  Fe-heme), the 
regulation of 6-aminolevulinate  synthetase (ALAS), 1 the rate-limiting  enzyme 
in the heme biosynthetic pathway (4), by heme itself has been proposed (2-4). 
According to  this  proposal,  heme  regulation  of ALAS formation  reflects the 
functioning of this metalloporphyrin complex as a  repressor of the formation of 
the enzyme protein, with cellular heme content and the rate of ALAS formation 
being reciprocally related. 
However,  it  was  recently  shown  in  studies  from  this  laboratory  (5-9)  and 
others  (10)  that  transition  metals  such  as  Fe  2+, 3+,  Cu,+. 2+,  and  Co  2+  have  a 
potent  ability to  alter  cellular  heme  metabolism  in  various  tissues of intact 
animals  and  in cells in culture as well.  Of these metals,  Co  2+ has been most 
extensively studied.  The effect of Co  2+ on hepatic ALAS formation in animals 
was  found  to  be  biphasic,  with  an  initial  inhibition  of the  enzyme  being 
followed by secondary or "rebound" induction of ALAS activity (6, 7). Moreover, 
both  in  whole  animals  and  in  cultured  hepatocytes,  Co  2÷  and  Cu '+  were 
capable of inhibiting  the induction  of ALAS by a  number of potent chemical 
inducers of the enzyme (7, 8). These findings raised the possibility that metals 
directly alter ALAS activity through their binding at a  regulatory site for the 
synthesis  of  the  enzyme  or  that  they  regulate  heme  synthesis  after  the 
formation  of metalloporphyrin  complexes  (7,  8)  which  in  turn  would repress 
ALAS by mimicking  the action of heme.  The  latter mechanism  was recently 
shown not to be required  for metals  to regulate  ALAS in liver,  because Pt  4÷ 
and  Ni  2÷, which do not enzymatically form heme complexes,  act similarly  to 
heme in controlling ALAS production (11). 
The present study was undertaken to study the enzymes of heme metabolism 
in  kidney  because  this  organ  responds  differently  from  liver  to  chemical 
agents-such  as porphyria-inducing  drugs  and steroids-which  potently alter 
heme  metabolism  in the  latter  organ.  In addition,  metal  ion effects on heme 
pathway enzymes in kidney were examined to test our hypothesis that nonheme 
complexed metals have the capacity to directly regulate heme synthesis in cells. 
Pt  4+  and  Ni  2÷  were used in  these  studies  because they do not enzymatically 
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form protoporphyrin-IX complexes. The results indicate that although these two 
elements  have  somewhat  differential  effects  on  heme  pathway  enzymes  in 
kidney as compared with liver  (11) they are capable of regulating  ALAS and 
heme oxygenase in the same manner as does heme itself. 
Materials  and Methods 
In Vivo Studies.  Male Sprague-Dawley rats were treated (subcutaneously)  with NiC12.6H~O 
(250 ~mol/kg), and PtK2C16" 6H20  (125  ~mol/kg). Tissues were prepared as described elsewhere 
(7). The whole homogenate was used for the determination of ALAS as described by Marver et 
al.  (12),  6-aminolevulinate  dehydratase  (ALAD),  according  to  the  method  of Mauzerall  and 
Granick (13), ferrochelatase by the method of Maines et al. (7), using dicarboxylic mesoporphyrin- 
IX  as  substrate  and  total  porphyrin  content  by  the  method  of  Granick  et  al.  (14).  The 
postmitochondrial cell fraction was used for assaying uroporphyrinogen-I-synthetase  (UROS) as 
described by Sassa et al. (15). Microsomal fractions were prepared and used for the determination 
of heine content (16). 
Whole cell homogenates and microsomal fractions obtained from untreated animals were used 
for  in  vitro  studies.  Small  volumes of solutions  of Ni  2+  and  Pt  4+  were  added  to  the  enzyme 
preparation used for the various assays to obtain desired final concentrations of compounds. 
Materials.  Reagents were purchased from the Sigma Chemical Co., St. Louis Mo. Porphobili- 
nogen, 8-aminolevulinic acid, and porphyrin standards (copro- and uroporphyrins) were purchased 
from Porphyrin Products, Salt Lake City, Utah. Dicarboxylic mesoporphyrin-IX was prepared as 
described elsewhere (17). 
Results 
Effect of Nickel on Heme Metabolism.  The time-courses of the effects of a 
single dose of Ni  2+ on renal  ALAS and heme  oxygenase activities and heme 
contents are depicted in Fig. 1. In contrast to hepatocytes (11) in which a single 
injection of Ni  2+ produces a  biphasic response in ALAS, with an initial  sharp 
decline  in  enzyme  activity followed by an  eventual  increase  to  levels  above 
normal,  ALAS activity of kidney did not exhibit the early inhibition response, 
but  remained  unchanged  for  12  h,  after  which  the  enzyme  activity  was 
substantially  increased.  As  shown  (Fig.  1),  in  the  kidney  Ni  2+  had  a  very 
marked effect on heme oxygenase with the enzyme activity being elevated at 
16  h  by  12  times  over the  control.  Moreover,  the  initial  inhibition  of heme 
oxygenase  which  was  observed  in  the  liver  (11)  was  not  noted  in  kidney. 
Microsomal content of heme in kidney which did not change during the first 3 
h  decreased substantially thereafter despite the elevation of ALAS. 
A  differential  effect of Ni  2+  on ALAD from hepatic  and  renal  sources was 
observed.  As  shown in Table I,  hepatic  ALAD  activity was not inhibited  by 
Ni  2÷, whereas ALAD of kidney was significantly inhibited 12 h after treatment 
and the inhibition was sustained for more than 24 h. Ferrochelatase and UROS 
activities were decreased slightly in both liver and kidney (10-15%) during the 
first 24 h and the total porphyrin contents of liver and kidney showed decreases 
3 h  after Ni  2+ treatment but had returned to normal at 16 h  (data not shown). 
The  time-courses  of the  Pt  4+  effects  on  enzymes  of heme  metabolism  in 
kidney are  shown in Fig.  2.  ALAS was significantly  depressed in the  initial 
hours after treatment with the metal. The early decline in ALAS lasted for 12 
h  and  was  followed by  a  sharply  increased  enzyme  activity  thereafter.  A 
decrease in cellular content of heme was noted by 3 h aider Pt  4+ treatment and 
was sustained for at least 24  h  despite the highly  elevated ALAS activity at 1288  ENZYMES  OF  HEME  METABOLISM  IN  THE  KIDNEY 
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FIG.  1.  The time-course of response to Ni  2÷ of heine pathway enzymes in rat kidney. Rats 
were treated (subcutaneously) with nickel chloride and then killed at indicated intervals. 
Various assays were performed using procedures detailed in the text. The values shown 
are the means of three determinations and are expressed as the percent of the control. The 
control value for heine oxygenase was 0.84  _+  0.21  nmol bilirubin/mg per h; control value 
for ALAS activity was 80  -+  18 pmol/mg per h; and that of microsomal heine was 0.30 
0.05 nmol/mg. 
TABLE  I 
Effect of In Vivo Ni ~+ Treatment on ALAD Activity in Kidney 
and Liver 
Tissue  Time  ALAD 
Kidney 
Liver 
h  nmol/mg/h 
0  2.87 
3  2.75 
12  2.01 
24  1.40 
0  4.50 
3  4.95 
12  4.72 
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FIG.  2.  The time-course of response to Pt  4+ of heme pathway enzymes in rat kidney. Rats 
were treated with platinum  (ic)  chloride.  Various assays were carried out as described 
in the text. The control values for the measured parameters were within _+ 10-20%  of the 
values given in the legend of Fig. 1. 
this time. The effects of Pt  4+ on heme oxygenase activity are also shown in this 
figure. Pt  4+ was a potent inducer of heme oxygenase in kidney as it was in the 
liver (11). 
Table II shows the effects of Pt  4+ on porphyrin content and on other enzymes 
of heme metabolism in kidney as compared with liver. In liver, ALAD, UROS, 
and ferrochelatase were decreased by 10-20% within 3-12 h after Pt  4+ treatment 
but  the  porphyrin  content  of this  organ  was  not  altered  by  the  metal.  In 
kidney,  Pt  4+  was  a  potent  inhibiter  of  -SH-dependent  enzymes  of  heme 
biosynthesis so that ALAD activity was depressed by 50-70%  in 12 h  with the 
decrease  in  enzyme activity being noted within 3  h  after treatment;  UROS 
activity at  this  time was  depressed  almost equivalently, and  ferrochelatase 
activity was reduced by 10-15%.  The total porphyrin content of kidney at 24 h 
was decreased markedly (60%) in contrast to the effect of the metal on liver 
porphyrin. 
Table III shows the in vitro effects of Pt  4+ and Ni  2+ on activities of ALAS, 
ALAD, and heme oxygenase in kidney and liver tissue preparations. In kidney, 
ALAD  and  heme  oxygenase,  the  latter  of which  is  also  a  -SH-dependent 
enzyme (]8), were markedly inhibited by Pt4+; high concentrations of Ni  2+ were 1290  ENZYMES  OF  HEME  METABOLISM  IN  THE  KIDNEY 
TABLE  II 
Effect of In Vivo Pt  4+ Treatment on Enzymes of Heme Biosynthesis and the Total 
Porphyrin Content in Kidney and Liver 
Ferrochela-  Total  por-  Tissue  Time  ALAD  UROS 
tase  phyrin 
Kidney 
Liver 
h  nmol/mg/h  pmol/mg/h  nmol/mg/h  pmol/mg 
0  2.55  220  2.33  15.80 
3  1.91  147  2.07  12.64 
12  1.02  125  2.05  9.95 
24  0.87  105  2.09  6.32 
0  4.45  460  4.47  4.12 
3  4.00  460  4.02  4.18 
12  4.00  373  3.66  4.12 
24  3.96  336  3.93  4.00 
TABLE  III 
In Vitro Effect of Ni 2+ and Pt  4+ on Hepatic and Renal Enzymes of Heine Metabolism 
Concentra- 
Organ  tion 
ALAS  ALAD  Heme oxygenase 
Ni  2+  pt  4+  Ni2+  pt~+  Ni~+  pt  4+ 
pM  %ofcontrol 
Kidney  125  100  101  93  70  100  69 
250  105  118  91  56  80  14 
Liver  125  100  105  111  51  105  96 
250  100  116  106  35  75  54 
ALAS and  ALAD activities  were  assayed  in  whole cell  homogenates after the  addition  of the 
indicated  concentrations of Ni  2+ and  Pt  4+.  Microsomal fractions were  used for heme oxygenase 
assays. 
also slightly inhibitory to these enzymes.  In liver, Ni  2+ did not inhibit ALAD 
but  Pt  4+ markedly  reduced its  activity.  Ni  2+  at high concentrations  was also 
inhibitory to heme oxygenase but Pt  4+ was considerably more effective in this 
regard. Pt  4+ did not inhibit the activity of either hepatic or renal ALAS; in fact, 
it increased this enzyme activity slightly at high concentrations. 
Discussion 
The results of the present study demonstrate that metal ions can regulate 
the activities of the two  enzymes which are rate  limiting in  cellular heme 
synthesis and heme degradation-ALAS and heme oxygenase, respectively- 
in the kidney as they do in the liver (11). These findings, considered together 
with previously published data from this laboratory (5-9),  thus  support the 
idea that these enzymes are under metal control in physiological circumstances. 
The  general  unresponsiveness  of kidney heme  pathway  enzymes to  those 
foreign chemicals that potently alter their activities in liver emphasizes the 
physiological significance of the renal enzyme response to metals, as shown in 
this study. 
In the present report, Ni  2+ and Pt  4+ were shown to produce long-lasting and 
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metals. Microsomal heme in this study paralleled total cellular heme contents, 
as reported previously (7). However, in the kidney, as was shown earlier with 
liver  (11),  the activity of ALAS was not consistently increased as a  reciprocal 
response  to the  substantial  reductions  observed in heme  content.  ALAS is a 
mitochondrial  enzyme  with  a  very  short  half-life  (2,  3),  and  prompt  and 
reciprocal  increases  in  ALAS would have been  expected  if formation  of this 
enzyme were solely regulated by a  feedback mechanism  involving heme as is 
generally believed.  Alternatively,  if the  metal-induced  reductions  of cellular 
heme had not decreased below the threshold levels of heme which would result 
in feedback derepression of ALAS synthesis (3), this enzyme activity would have 
been expected to remain unaltered. Rather, Pt  4+ produced concurrent reductions 
in both ALAS and total cellular heme content, and Ni  2+ produced a substantial 
reduction  of cellular heme  at a  time  (12 h,  Fig.  1) when ALAS activity was 
unaltered. 
The possibility that the metals directly complexed with ALAS to depress its 
activity can be excluded because high  concentrations  of Ni  2+  and  Pt  4+  when 
directly added to the enzyme in vitro did not diminish its activity. It can be con- 
cluded, therefore, that in the experiments described here the exogenous metal 
ions-rather  than the cellular concentrations  of Fe-heme-directly exerted an 
inhibitory  effect on the synthesis of ALAS.  Direct regulatory  actions of Ni  2+ 
and  of Pt  4+  on ALAS are  consistent with our previous findings  with  Co  2+  in 
whole animal  liver and  avian  embryo hepatocytes grown in tissue culture  in 
which  Co  z+  blocked the  de  novo  synthesis  of ALAS  in  the  same  fashion  as 
does Fe-heme  (7, 8). 
These findings make it clear that metal ions,  independent of their ability to 
form  intracellular  complexes  with  proteporphyrin-IX  (19),  can  mimic  the 
regulatory action of Fe-heme on the rate-limiting  enzyme of heme synthesis, 
ALAS.  Fe-heme  and  metal  ion  control  of ALAS  results  from  inhibition  of 
enzyme  protein  synthesis  (3,  8);  this  inhibition  by  metals  is  followed by a 
rebound induction phenomenon  (6). The exact cause of the induction of ALAS 
after  the  initial  repression  of its  synthesis  is  not  known,  but  it  has  been 
suggested  (1,  2)  that  the  increase  reflects  derepression  of enzyme  synthesis 
subsequent to the initial inhibition. 
The decrease in heme content,  which was observed when the heme biosyn- 
thetic pathway was functioning at an apparently unaltered rate,  as judged by 
the total porphyrin content, and ALAS and ferrochelatase activities (e.g.  12-24 
h  after Ni  2+ treatment)  is most likely due to the concomitant increase  in the 
rate of heme degradation  mediated by the metal.  Ni  2+ and Pt  4+ both substan- 
tially induced heine oxygenase activity in the kidney and this was associated 
with depletions of heme contents in this organ. In previous studies in liver, with 
isotopically labeled heme, we have shown that such decreases of cellular heme 
content result  from induced  heme  oxygenase activity  (20,  21).  It  can  be rea- 
sonably assumed therefore that  enhanced  heme  oxygenase activity similarly 
accounts for the reduction of renal heme contents observed in the present study. 
On  the  basis  of the  findings  described  in  this  report  and  evidence  from 
previous  studies  (5-9,  11),  it  is  proposed  that  metal  ions  act  directly  as 
physiological regulators of ALAS production and that the well-known Fe-heme 
repression  of synthesis  of this  enzyme  essentially  reflects the  ability  of this 1292  ENZYMES  OF  HEME  METABOLISM  IN  THE  KIDNEY 
metalloporphyrin  chelate  to facilitate  the  intracellular  transport  of metal  to 
the  regulatory  site  of ALAS  production.  According  to  this  formulation,  the 
metal  moiety of Fe-heme,  rather  than  the tetrapyrrole  nucleus,  is the  proxi- 
mately active chemical species for control of ALAS, and synthesis of  this enzyme 
is regulated either by free metal ion released from the metalloporphyrin chelate 
through heme oxygenase action, or by coordination of the chelated metal at the 
enzyme regulatory site. Control of heme oxygenase synthesis directly by metal 
ions alone is also postulated to occur in similar fashion. 
Summary 
The in vivo regulation by metal ions of the enzymes of heme metabolism in 
kidney-particularly  of ALAS, the rate-limiting  enzyme in heine formation- 
was investigated. Ni  2+ and Pt  4+, metals which do not enzymatically  form 
metalloporphyrins, were found to regulate  ALAS in kidney as they do in liver. 
The pattern  of  this  regulation  was generally  similar  to  that  observed with heme 
and metal ions  in liver,  i.e.,  a late  increase  in enzyme activity  aider  an early 
period in which ALAS activity  was unaltered or inhibited.  The metals did not 
interact  with the enzyme in vitro  to alter  its activity.  In this  study no direct 
reciprocal  relationship  between ALAS activity  and total  cellular  heine content 
was demonstrated. The metal ions,  particularly  Pt  4+, also  altered  the activity 
of  other enzymes of heme biosynthesis in kidney. Pt  4+ severely inhibited  the 
activity of ALAD  and UROS.  Ni  2+ and Pt  4+ were potent inducers of heme 
oxygenase, the initial  and rate-limiting  enzyme in heine degradation. 
It  is  proposed that the physiological  regulation  of  ALAS is  mediated through 
the action  of  metal ions,  rather than by the cellular  content of  heine,  and that 
the regulation of  ALAS by heine reflects  the action  of  the central  metal ion of 
heme rather than that of  the entire  metalloporphyrin complex. In  this  proposed 
mechanism for metal ion regulation of  ALAS, the tetrapyrrole  moiety of  heine 
is considered to function principally as an efficient  carrier  of metal to the 
regulatory site  for ALAS production, inasmuch as the tetrapyrrole  ring itself 
has been shown in earlier  studies  not to have any effect  on ALAS activity.  The 
production of  heine oxygenase is believed  to be similarly  regulated. 
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